IN2014DN10077A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10077A
IN2014DN10077A IN10077DEN2014A IN2014DN10077A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A IN 10077DEN2014 A IN10077DEN2014 A IN 10077DEN2014A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A
Authority
IN
India
Prior art keywords
carbon content
organic carbon
less
during
total organic
Prior art date
Application number
Other languages
English (en)
Inventor
Kazuhiro Obae
Masayuki Kakizawa
Mitsuo Yamashita
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Publication of IN2014DN10077A publication Critical patent/IN2014DN10077A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/122—Pulverisation by spraying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates
    • C08K5/053—Polyhydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/04—Oxycellulose; Hydrocellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
IN10077DEN2014 2012-05-31 2013-05-30 IN2014DN10077A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012124016 2012-05-31
PCT/JP2013/065111 WO2013180246A1 (ja) 2012-05-31 2013-05-30 セルロース粉末

Publications (1)

Publication Number Publication Date
IN2014DN10077A true IN2014DN10077A (da) 2015-08-21

Family

ID=49673433

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10077DEN2014 IN2014DN10077A (da) 2012-05-31 2013-05-30

Country Status (3)

Country Link
JP (3) JP6210981B2 (da)
IN (1) IN2014DN10077A (da)
WO (1) WO2013180246A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6210981B2 (ja) * 2012-05-31 2017-10-11 旭化成株式会社 セルロース粉末
JP5950012B1 (ja) * 2015-09-17 2016-07-13 王子ホールディングス株式会社 微細繊維状セルロース含有物の製造方法
JP6638290B2 (ja) * 2015-09-30 2020-01-29 日本製紙株式会社 粉末状セルロース
US20220062182A1 (en) * 2018-12-27 2022-03-03 Asahi Kasei Kabushiki Kaisha Cellulose powder, use thereof, and tablets
WO2020202598A1 (ja) * 2019-04-02 2020-10-08 旭化成株式会社 セルロース粉末、錠剤及び錠剤の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420126A (en) * 1977-07-12 1979-02-15 Asahi Chem Ind Co Ltd Pharmaceutical composition
JP3534130B2 (ja) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 医薬品組成物
CN1296387C (zh) * 2000-07-05 2007-01-24 旭化成株式会社 纤维素粉末
EP1634908B1 (en) * 2003-05-30 2017-01-11 Asahi Kasei Kabushiki Kaisha Cellulose powder
JP2005232260A (ja) * 2004-02-18 2005-09-02 Asahi Kasei Chemicals Corp セルロース無機化合物多孔質複合粒子
WO2006115198A1 (ja) * 2005-04-22 2006-11-02 Asahi Kasei Chemicals Corporation 多孔質セルロース凝集体及びその成型体組成物
WO2009157564A1 (ja) * 2008-06-26 2009-12-30 旭化成ケミカルズ株式会社 セルロース組成物
JP5430091B2 (ja) * 2008-07-09 2014-02-26 旭化成せんい株式会社 高吸水性樹脂およびその製造方法
JP5759457B2 (ja) * 2010-06-29 2015-08-05 旭化成ケミカルズ株式会社 セルロースと無機化合物を含む複合粒子
AU2012265933B2 (en) * 2011-06-06 2016-03-17 Trudell Medical International Inc. Oscillating positive expiratory pressure device
JP6210981B2 (ja) * 2012-05-31 2017-10-11 旭化成株式会社 セルロース粉末
EP2857421B1 (en) * 2012-05-31 2018-03-07 Asahi Kasei Kabushiki Kaisha Cellulose powder
US9592199B2 (en) * 2012-05-31 2017-03-14 Asahi Kasei Chemicals Corporation Cellulose powder
JP6413940B2 (ja) * 2015-06-11 2018-10-31 株式会社デンソー 運転支援装置

Also Published As

Publication number Publication date
JP6210981B2 (ja) 2017-10-11
JPWO2013180246A1 (ja) 2016-01-21
JP2017165972A (ja) 2017-09-21
JP6383835B2 (ja) 2018-08-29
WO2013180246A1 (ja) 2013-12-05
JP2018172699A (ja) 2018-11-08

Similar Documents

Publication Publication Date Title
IN2014DN10072A (da)
IN2014DN10076A (da)
IN2014DN10077A (da)
MX2014015389A (es) Metodos para incrementar el contenido de caucho extraible de material de planta no hevea.
CA3073378C (en) Rubber composition comprising a farnesene polymer and tire
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
IN2014CN02317A (da)
MX364734B (es) Procesos de recuperación de caucho de briquetas envejecidas y briquetas envejecidas que contienen materia vegetal de plantas no hevea.
MX2013010890A (es) Hibrido de pigmento autoaglutinante.
EP3838930A3 (en) Polymerisation process
MX2020008008A (es) Proceso para desvulcanizar bacterianamente particulas de caucho vulcanizadas con azufre.
WO2011124189A3 (en) Method for the production of hydrogen and other products and device for carrying out this method
NZ717098A (en) Vancomycin derivative, and preparation method and application thereof
IN2015MN00013A (da)
WO2015145054A3 (fr) Reacteur implantable biocompatible
EP3791406A4 (en) IMPROVED UF TRANSPORT AND PROCESS VESSEL (30W) FOR ENHANCEMENTS UP TO 20% BY WEIGHT
MY163074A (en) Formulations comprising methylthioninium chloride
MX2012010850A (es) Proceso continuo para preparar particulas de polifluoroacrilato.
MY175060A (en) Method for processing rubber granules or rubber powders
MY162164A (en) Process for production of polymer nanocomposites
GB201008401D0 (en) Novel process
MX346317B (es) Succinilato de caseina de hierro (iii) y metodo para la preparacion del mismo.
IN2012DN06607A (da)
MY171853A (en) Sphingomyelin-containing supplement
PT2928927T (pt) Processo para produção de composições de éster de polivinilo com baixo teor de de monómero residual